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Abstract
Background Renewed interest has developed in decom-
pressive craniectomy, and improved survival is shown when
this treatment is used after malignant middle cerebral artery
infarction. The aim of this study was to investigate the fre-
quency and possible risk factors for developing surgical site
infection (SSI) after delayed cranioplasty using autologous,
cryopreserved bone.
Methods This retrospective study included 74 consecutive
patients treated with decompressive craniectomy during the
time period May 1998 to October 2010 for various non-
traumatic conditions causing increased intracranial pressure
due to brain swelling. Complications were registered and
patient data was analyzed in a search for predictive factors.
Results Fifty out of the 74 patients (67.6 %) survived and
underwent delayed cranioplasty. Of these, 47 were eligible for
analysis. Six patients (12.8 %) developed SSI following the
replacement of autologous cryopreserved bone, whereas bone
resorption occurred in two patients (4.3 %). No factors pre-
dicted a statistically significant rate of SSI, however,
prolonged procedural time and cardiovascular comorbidity
tended to increase the risk of SSI.
Conclusions SSI and bone flap resorption are the most fre-
quent complications associated with the reimplantation of au-
tologous cryopreserved bone after decompressive craniectomy.
Prolonged procedural time and cardiovascular comorbidity
tend to increase the risk of SSI.
Keywords Cranioplasty . Craniectomy . Autologous .
Cryopreserved . Surgical site infection . Complications
Introduction
Decompressive craniectomy is a lifesaving surgical procedure
in acute brain swelling [12, 49]. The technique was first
described by Harvey Cushing in 1905 [10]. Common causes
of acute brain swelling are malignant middle cerebral artery
(MCA) infarction, aneurismal subarachnoid hemorrhage
(aSAH), intracerebral hemorrhage (ICH), traumatic brain in-
jury (TBI), acute subdural hematoma (ASDH), and reactive
edema after intracranial surgery. The procedure was first in-
troduced for MCA infarction in 1956 [44].
For those who survive, the cranial defect after decom-
pressive craniectomy is usually reconstructed at a later
point of time. Cranioplasty is performed for the following
reasons: protection of the brain, restoration of the brain's
hydrodynamic conditions [14, 29, 51, 52], and cosmetics.
Cranioplasty can be performed by using autologous bone
or patient-specific prostheses made of various alloplastic
materials [6, 9, 23, 31]. Autologous bone is often pre-
ferred to allograft due to its perfect match to the bony defect
and low cost.
Surgical site infection (SSI), defined as infection resulting
in surgical removal of the implanted bone, is a feared compli-
cation in delayed cranioplasty. This retrospective study was
conducted to identify complications after cranioplasty with
cryopreserved autologous bone and to search for possible risk
factors associated with the development of SSI.
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The study includes all patients from over a period of 12.5 years
(May 1998 to October 2010) that underwent (1) decom-
pressive craniectomy for acute brain swelling, (2) cryopreser-
vation of the removed bone flap, and (3) reimplantation of the
bone flap at the Neurosurgical Department, Oslo University
Hospital Rikshospitalet, Oslo, Norway. Rikshospitalet is a
tertiary-level university hospital that does not manage trauma
patients.
Patients who had their reimplanted cryopreserved bone flaps
removed due to SSI or bone flap resorption later underwent a
secondary cranioplasty using a prefabricated, patient-specific
prosthesis made of porous, biocompatible polyethylene
(Medpore biomaterial customized implant. Porex Surgical,
Inc. 15 Dart Road, Newnan, GA 30265-1017 USA).
Methods
Surgical procedures
Decompressive craniectomy In the decompressive
craniectomy procedure, a standard frontotemporoparietal
hemicraniectomy was performed, whereupon the dura mater
was opened in a stellate fashion. A dura substitute (Neuro-
Patch® Aesculap AG, Am Aesculap-Platz, 78532 Tuttlingen)
was then placed over the cerebral cortex, and the opened dura
was repositioned over the substitute. In the past few years, a
second dura substitute was positioned between the dura and
the temporal muscle in order to ease surgical dissection of the
temporal muscle during cranioplasty. The subcutis and cutis
were closed separately. Connective tissue and blood were
removed from the bone flap. The flap was immediately there-
after washed in sterile H2O2 and NaCl 9 mg/ml dried with
sterile gauze, packed in a two-layer sterile instrument pouch
(3 M Health Care 9097 St. Paul, MN 55144–1000 USA), and
placed in an ultra-low freezer (Forma Scientific Inc. SA mod.
925, 401 Mill Creek Rd, Marietta, OH 45750) at - 86 °C.
Primary cranioplasty At primary cranioplasty, the bone flap
was retrieved from the freezer when the patient arrived in the
operating theater and then was thawed at room temperature.
The sterile instrument pouch was opened and the bone placed
in sterile Gentamycin-/NaCl solution. The cutis and subcutis
were cut open corresponding to previous incisions and dis-
sected from the cranium and the temporal muscle. The tem-
poral muscle was carefully dissected from the dura, avoiding
any CSF leak. The edges of the scull at the previous
craniectomy site were trimmed using a drill and a diamond
burr so that the cranium and the bone flap matched exactly.
The bone was then put into place and fixed to the scull using a
craniofix (B Braun Aesculap Tuttlingen Germany) and/or the
Lorenz plating system (Biomet microfixation 1520 Tradeport
Drive Jacksonville FL 32218–2480). The temporal muscle
was reattached to the temporal bone with sutures against
small, separate burr holes when it was straightforward in order
to dissect the muscle. In cases where the muscle was adherent
and difficult to release from the dura, the bone flap was
replaced over the muscle. The selected method was dependent
on the individual surgeon’s choice. Eight different surgeons
with varying levels of experience have performed the primary
cranioplasty procedures on the patients in this study.
Secondary cranioplasty During secondary cranioplasty, the
surgical procedure until adequate exposure of the cranial
defect was performed as described during the primary
cranioplasty. A prefabricated patient-specific prosthesis was
trimmed and fitted to match the cranial vault exactly and fixed
to the scull using the Lorenz plating system, as described
previously by the authors [47].
Data obtained from the patients’ medical journals
The following data were obtained retrospectively from the
patients’ medical journals: age, sex, smoking habits, previous
medical history, etiology of the brain swelling leading to
decompressive craniectomy, side of craniectomy, prophylactic
antibiotic treatment, duration of the primary cranioplasty sur-
gical procedure (minutes), subcutaneous drainage after
cranioplasty, in-hospital infection, time from decompressive
craniectomy to cranioplasty (days), and follow-up (months).
The complications recorded after cranioplasty were SSI,
post-operative hematoma, and bone resorption resulting in
repeat surgery.
Ethical considerations
This study is part of a retrospective follow-up trial on patients
with MCA infarction, approved by the Regional Committee
for Medical and Health Research Ethics, and the data protec-
tion official for research. The present analysis was separately
evaluated by the Regional Committee for Medical and Health
Research Ethics as a quality assurance of existing treatment,
and an additional special committee approval was therefore
not needed. The study was also approved by the data protec-
tion official for research.
Statistical analysis
Categorical variables are presented as absolute values and
percentages. Continuous, normally distributed data are pre-
sented asmeans and standard deviations (SD). Between-group
differences were determined by χ2 statistics or Fischer's exact
tests, as appropriate, and unpaired two-sample t tests. Time
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intervals are presented as medians and interquartile ranges
(IQR), and between-group differences were analyzed using
the Mann-Whitney U test.
A p value <0.05 was used as level of significance. All
statistical analyses were performed using SPSS 18.0.
Results
Patient cohort
A total of 74 patients (38 females and 36 males) underwent
decompressive craniectomy. Their mean age was 49 years
(range 6–78 years). Craniectomy was performed due to
MCA infarction in 47 patients (63.5 %), aSAH in 17 (23 %),
ICH or ASDH in seven (9.5 %), and reactive brain edema
following tumor surgery in three (4.0 %). The craniectomy
was unilateral in 73 patients and bifrontal in one. Fifty out of
74 patients (68.4 %) survived and had their bone flap replaced
at a later point of time. Three patients were foreign tourists
who had their bone flap replaced 4 to 26 days after decom-
pressive craniectomy (before repatriation to their home
country). None of them developed SSI during the hospital
stay in Oslo. All three were lost to follow-up.
Thus, 47 patients, 20 females and 27 males with a median
age of 47.8 years (range 6–74 years) were eligible for analysis
and included in the study. Among these, decompressive
craniectomy was performed for the following reasons: MCA
infarction in 31 patient (66.0 %), aSAH in 11 (23.4 %), ICH or
ASDH in four (8.5%), and reactive edema after tumor surgery
in one (2.1 %). Clinical data of the 47 patients are presented in
Table 1. They were followed for a median of 41months (range
2–155 months).
Primary cranioplasty
The median time from decompressive craniectomy to
primary cranioplasty was 97 days (range 38-568 days).
The median duration of the surgical procedure was 115 min
(range 40–230 min).
Two patients (4.3 %) underwent surgical removal of a
postoperative epidural hematoma within 6 h after the
cranioplasty. Their bone flaps were replaced immediately after
evacuation of the hematoma. None of these two patients had a
subcutaneous drainage placed in connection with the primary
procedure.
SSI, bone resorption, and bone flap removal
Six patients (12.8 %) developed SSI following replacement of
the autologous cryopreserved bone. The bone flaps were
removed 5, 17, 39, 119, 164, and 729 days, respectively, after
the primary cranioplasty. The pathogens found and assumed
to be responsible for the infections were: E. coli after 5 days,
Propionibacterium acnes after 39 and 119 days, Methicillin-
resistant Staphylococcus aureus after 164 days, and S. aureus
after 17 and 729 days. Two of the six patients that developed
SSI (P. acnes after 39 days and S. aureus after 17 days) had for
unknown reasons not received prophylactic antibiotic treat-
ment prior to replacement of their cryopreserved bone.
However, there was no statistical significant difference in the
rate of SSI among those who received prophylactic antibiotics
and those who did not (p=0.61) (Table 1).
All six patients that developed SSI were treated with anti-
biotics following antimicrobial susceptibility testing for 4 to 8
weeks after removal of the implanted bone.
Two patients, a 6-year-old boy and a 61-year-old woman,
had their bone flaps removed due to bone resorption 1,645 and
1,000 days, respectively, after cranioplasty.
Seven of the eight patients who had their bone flaps re-
moved later underwent a secondary cranioplasty using a
patient-specific prosthesis made of porous, biocompatible
polyethylene. The eighth patient died a few weeks before
planned secondary cranioplasty. None of the patients devel-
oped SSI after the secondary cranioplasty.
Patient groups and SSI resulting in bone flap removal
The background characteristics for all patients (n=47) and the
groups with (n=6) or without SSI (n=41) are presented in
Table 1. There was no statistical significant difference be-
tween the two groups in any of the variables. There was,
however, a trend towards more cardiovascular disease (SSI
in 4/6 [67 %] versus non-SSI in 10/41 [24 %]; p=0.06), and
longer surgical procedure in the SSI group (median; SSI
148 min [IQR, 110–240 min] versus non-SSI 114 min [IQR,
90–142 min]; p=0.06).
Discussion
In the present study, eight out of 47 patients who underwent
decompressive craniectomy and primary cranioplasty with
autologous cryopreserved bone had their replaced bone flap
removed again later due to SSI (six patients) and bone resorp-
tion (two patients). In the SSI group, there was a trend toward
longer surgical procedure and more cardiovascular disease.
None of the patients developed SSI after secondary
cranioplasty using patient-specific cranial prosthesis.
Preservation of bone flaps
Bone flaps removed during decompressive craniectomy are
often preserved in a deep freezer, but the practice differs with
regard to the freezing temperature used, ranging from −16 °C
to −84 °C [2, 25, 26, 34, 37, 42]. Iwama et al. evaluated the
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complication rates at different freezing temperatures (−84 °C
versus −35 °C). Among their 47 patients, one developed SSI
and one experienced bone flap resorption, both occurring in
the group with a storage temperature of −35 °C [26].
Cranioplasty
Although various alloplastic materials such as stainless steel
mesh-acrylic [15], titanium [27, 46], methyl methachrylate [4,
5], and customized prefabricated prostheses [9, 11, 13, 16, 47]
are available for cranioplasty, most surgeons prefer to use the
patient’s own bone whenever possible. A review of the most
common mode of skull defect reconstruction in 25 major
neurosurgical centers in Australia showed that 96 % preferred
the use of cryopreserved autologous bone [3]. The use of
autologous bone has the advantages of an ideal geometrical
fit. Also, bone flaps kept frozen for up to 19 months have been
shown to have the capacity for revitalization through a process
of revascularization, resorption, and accretion [42]. Oh et al.
demonstrated that osteoblast-like cells can survive in frozen
bone [39], which concurs with clinical, radiologic, and radio-
nuclide studies indicating the same [22].
SSI after cranioplasty with cryopreserved bone
The use of cryopreserved autologous bone in the reconstruc-
tion of the cranial defect after craniectomy entails a risk for
developing SSI. The infection rate varies between studies,
from 0 to 25.9 % with an average of 7.7 % (Table 2) [2, 7,
19, 24–26, 32, 34–37, 42, 53].
At some institutions, the removed bone flaps are routinely
examined for bacterial contamination prior to storage. Chiang
et al. found that the frequency of SSI did not increase after
reimplanting bone flaps contaminated with microorganisms
such as P. acnes, coagulase-negative Staphylococci, and S.
aureus [8]. However, the risk of SSI in the reimplantation of
bone flaps with positive bacterial cultures prior to preservation
has not been determined. The same pathogens mentioned
above were involved in five out of six cases of SSI in our
patients. We do not know if they were contaminated before
cryopreservation, since bacteriological examination of the
bone flap prior to preservation has not been implemented as
routine in our department.
We did not find any statistically significant relationship
between the time interval from decompressive craniectomy
to primary cranioplasty and the risk of SSI. This is in accor-
dance with several previous studies [17, 41, 50], but in con-
trast with others, who have shown benefits from delaying the
cranioplasty procedure [20, 43, 48]. However, we found a
non-significant trend toward prolonged operation time being
associated with an increased risk of SSI. This corresponds
well with the findings in two recently published studies by
Kim H et al. and Lee et al. [28, 30], but contrasts with the
results of Tokoro et al [48]. According to Manson et al., the
risk of SSI increases from about 5 % in routine primary
cranioplasty to 14 % during a second cranioplasty [33].
Table 1 Background characteris-
tics of 47 patients who underwent
delayed cranioplasty
Values are n and (%), unless in-
dicated otherwise
a Known prior to craniectomy and
considered stable disease: two pa-
tients with breast cancer, one with
ovarian cancer, one with cervical
cancer, and one with testicular
cancer
b Chronic obstructive pulmonary
disease
c Pneumonia, urinary infection,
sepsis, and infection without
known focus requiring postopera-
tive antibiotic treatment
All n=47 SSI n=6 Non-SSI n=41 P
Age, mean (SD) 47.8 (13.1) 48.2 (13.4) 47.7 (13.3) 0.94
Male sex 27 (57.4) 4 (66.7) 23 (56.1) 1.00
Smoking 12/39 (30.8) 2/5 (40.0) 10/34 (29.4) 0.63
Comorbidity
Diabetes 5 (10.6) 1 (16.7) 4 (9.8) 0.51
Cancera 5 (10.6) 0 (0) 5 (12.2) 1.00
COPDb 3 (6.4) 0 (0) 3 (7.3) 1.00
Cardiovascular disease 14 (29.8) 4 (66.7) 10 (24.4) 0.06
Cause of craniectomy
MCA infarction 31 (66.0) 2 (33.3) 29 (70.7) 0.16
SAH 11 (23.4) 3 (50.0) 8 (19.5) 0.13
Tumor cerebri 1 (2.1) 1 (16.7) 0 (0) 0.13
ICH/ASDH 4 (8.5) 0 (0) 4 (9.8) 1.00
Right-sided 28 (59.6) 2 (33.3) 26 (63.4) 0.20
In-hospital infection after craniectomyc 40 (85.1) 5 (83.3) 35 (85.4) 1.00
Time from craniectomy to cranioplasty in days,
median (IQR)
97 (82–120) 94 (74–164) 101 (83–121) 0.70
Operation time in min, median (IQR) 115 (95–159) 148 (110–204) 114 (90–142) 0.06
Prophylactic antibiotics 36 (76.6) 4 (66.7) 32 (78.0) 0.61
Post-operative subcutaneous drainage 16 (34.0) 3 (50.0) 13 (31.7) 0.40
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None of our six patients developed SSI following secondary
cranioplasty using patient-specific cranial prosthesis.
Prophylactic antibiotics were administered less often in the
SSI group (67 %) compared to the non-SSI group (78 %) in
our study. The difference was, however, not statistically sig-
nificant. Prophylactic antibiotics are not standard treatment in
our department and are therefore dependent on the surgeon’s
preference. This is probably the reason why not all patients
received prophylactic antibiotics.
In the present study, there was no association be-
tween the etiology of craniectomy and SSI following primary
cranioplasty. Walcott et al. found, however, that stroke pa-
tients had a higher risk of SSI after cranioplasty than trauma
patients [50], but no trauma patients were included in our
study. Moreover, no statistically significant association was
found between SSI and patient age, sex, prophylactic antibi-
otics or postoperative subcutaneous drainage. These findings
correspond well with the results of Tokoro et al [48].
Bone resorption after cranioplasty
Several authors have reported on the risk factors for develop-
ing bone resorption following cranioplasty with autologous
bone [1, 2, 21, 38, 40, 42]. Hancock et al. found that 10 out of
12 sterilized, reimplanted bone flaps resorbed in children
younger than 13 years [21]. Also, others have reported an
increased risk of bone flap resorption in very young children
[40, 42].
In our study, bone flap resorption occurred in a 6-year-old
boy and in a 61-year-old woman 1,645 and 1,000 days,
respectively, after cranioplasty. The follow-up period for all
patients was median 41 months (range 2–155 months). One
might suspect that a longer follow-up period in the present
study could have revealed bone resorption in more patients.
However, Schuss et al. found in their study that 60 % of bone
flap resorption occurred within 1 year of follow-up and that no
resorption was observed among patients followed for more
than 5 years [45]. On the other hand, in a study by Grant et al.
on patients younger than 19 years, bone resorption occurred in
20 out of 40 patients. Cranioplasty was performed with autol-
ogous bone following decompressive craniectomy and bone
resorption occurred a mean 13.3 months (range 2–76 months)
after primary cranioplasty [18].
Autoclaving the frozen bone before reimplantation in order
to reduce the risk of SSI [1, 2, 21, 38, 40], along with shunt
procedures [2] both seem to increase the risk of bone flap
resorption.
Limitations of our study
Our study is a retrospective analysis and may suffer from
anticipated deficiencies related to the loss of patient informa-
tion. Various neurosurgeons with possibly differing operative
techniques and assessments of indication for surgery, as well
as the heterogeneous patient population may have influenced
the study results. In addition, the small sample size precludes
firm conclusions about the risk factors related to SSI.
Conclusion
SSI was the most common complication of the reimplantation
of autologous cryopreserved bone after decompressive
craniectomy seen in this study. Prolonged procedural time
and cardiovascular comorbidity seemed to increase the risk
of SSI. Because of the limited power of the study, it is,
however, impossible to draw reliable conclusions, and further
larger trials are required.
Table 2 Reported SSI in
cranioplasty with autologous
bone
N/A indicates not available
Author N Implant Preservation SSI
Moreira-Gonzales et al. [35] 312 Autologous bone N/A 22 (7.1 %)
Matsuno et al. [34] 54 Autologous bone Cryopreservation −20 °C 14 (25.9 %)
Iwama et al. [26] 37 Autologous bone Cryopreservation −35 °C 1 (2.7 %)
12 Autologous bone Cryopreservation −84 °C 0 (0 %)
Inamasu et al. [25] 31 Autologous bone Cryopreservation −70 °C 5 (16.1 %)
39 Autologous bone Subcutaneous pocket 2 (5.1 %)
Huang et al. [24] 151 Autologous bone Cryopreservation −75 °C 5 (3.3 %)
Lu et al. [32] 16 Autologous bone Cryopreservation −80 °C 0 (0 %)
Cheng et al. [7] 52 Autologous bone Cryopreservation −?°C 7 (13.5 %)
Grossmann et al. [19] 12 Autologous bone Cryopreservation −80 °C 0 (0 %)
Prolo et al. [42] 53 Autologous bone Cryopreservation −20 °C 2 (3.7 %)
Asano et al. [2] 110 Autologous bone Cryopreservation −40 °C 5 (4.5 %)
Nagayama et al. [37] 208 Autologous bone Cryopreservation −16 °C 8 (3.88 %)
Zingale et al. [53] 21 Autologous bone Cryopreservation −18 °C 0 (0)
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Comments
This interesting retrospective analysis presents results of cranioplasty
with autologous cryopreserved bone flaps after decompressive
craniectomy in a diverse group of 47 patients. In this article, the authors
evaluated the type and rate of complications and sought to answer the
important question of whether there are any specific risk factors for
developing surgical site infections (SSI). Although not statistically sig-
nificant, it is interesting that both prolonged procedural time and cardio-
vascular comorbidity seem to increase the risk of SSI. However, if one
analyzes the data in detail, several other factors such as smoking, diabetes,
subarachnoid haemorrhage as the cause of craniectomy, avoidance of
prophylactic antibiotics, and even insertion of subcutaneous drainages
also may have influenced the incidence of SSI in the present series. The
authors acknowledge the various limitations of the study, which are
mainly the retrospective design and the small patient sample size. Further
prospective analyses with larger cohorts will be needed, and hopefully
may yield more concrete insight on this topic, may validate the findings
provided, and may allow us to draw more definite conclusions.
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